Female Health Company (NASDAQ:FHCO)
FHCO is extremely oversold as the market is punishing perceived weak earnings resulted from the last quarter earnings release, plus the market doesn't understand the importance and need of its product, there's little to no sell side coverage and the market doesn't have the patience for the quarter-to-quarter (QTQ) natural - albeit unpredictable - volatility. FHCO is extraordinary profitable, very high and stable margins, no debt, market share of close to 100% for its main and only product with exponential growth rates the last couple of years with a very high probability of even higher growth rates the next couple of years.
FHCO has a massive moat, wonderful economics, and a...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|